Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION
2024-517384-24-00Phase 2Authorised
- Sponsor
- Assistance Publique–Hôpitaux de Marseille
- Start
- Sep 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in scarred vocal fold comparing SVF injection with Placebo injection (2 arms). Primary endpoint: Change from baseline in Voice Handicap Index (VHI) total score. Planned start Sep 2022; status: authorised.
02
Drugs
autologous adipose-derived stromal vascular fraction cells
03
Conditions
scarred vocal fold
Beyond the preview
Go deeper on 2024-517384-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517384-24-00.